Fiche centre
Praxis Research Site
São Paulo — Brazil
Essais liés3clinical trials
VilleSão Paulolocalisation
PaysBrazillocalisation
SourcelocaleCSV/MySQL
Informations
centreImport ClinicalTrials.gov
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| PRAX-222 - Initial Dose | Épilepsie | Phase 1/2 | NCT05737784 | A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy | ACTIVE_NOT_RECRUITING |
| 1mg elsunersen | Épilepsie | Phase 3 | NCT07019922 | A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety | RECRUITING |
| 1.0mg/kg/day PRAX-562 | Épilepsie | Phase 3 | NCT07010471 | EMERALD — A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine | ACTIVE_NOT_RECRUITING |